Abstract
456
Morse, P.F. and Horrobin, D.F.
Objective assessment of the effects of Epogam on skin smoothness as assessed by profilometry in both normal controls and patients with atopic eczema
Fat Sci Technol 1988; 7: 268-271.


Abstract

Profilometry was used to measure the roughness or a standard area of skin in normal individuals and of a similar area of non-inflamed skin in patients with atopic eczema. The skin roughness in atopic eczema patients was significantly greater than in controls. Treatment for four weeks with six 0.5g capsules/day of Epogam produced a modest reduction in skin roughness in controls and a highly significant reduction in roughness in atopic eczema patients. At the end of the Epogam treatment, skin roughness in patients and controls was similar.


All copyrights acknowledged

© Peter Lapinskas 1999-2012 Email Peter Lapinskas Last updated: 3 July 2012

Home      Services      Background      Publications      Resources      Contact